Pharmaceutical Network January 9 hearing in Europe and the United States, to the hospital, making a CT, according to what NMR, may be used is 'Made in Shenzhen' medical equipment. The latest data show that independent research and development production in Shenzhen Class medical device products, now covering more than 200 countries and regions.
Shenzhen is the earliest city to develop the medical device industry in China, accounting for nearly one-fifth of its output value and over 10 years of leadership in the Chinese medical device industry.However, in recent years, with the rise of the medical device industry in Suzhou and Shandong, Shenzhen industry leaders continue to decline, regardless of the proportion of the national output or the growth rate of growth are declining year by year, while the current medical equipment industry in Shenzhen has not yet a core innovation park, businesses have also moved across the layout or relocation.
Recently, the reporter learned that Shenzhen will promote the transformation and upgrading of medical equipment industry from the aspects of medical institution construction, industry-university-institute collaborative innovation, improvement of industrial facilities and other aspects, and boosting Medical equipment industry to create another advantage.
Status quo - the national share of output value fell from 19.4% to 8.8%
'Shenzhen medical device industry in the country once thriving.' Talk about the history of Shenzhen medical device industry, Shenzhen Medical Device Industry Association, Cai Qiao Wu feel very much. Shenzhen is China's first magnetic resonance imaging system, China's first Taiwan Choi Chao, China's first fully automatic biochemical analyzer and other origin of independent innovation products, calendar year output value among the nation's largest cities, in 2006 accounted for nearly one-fifth of the country.
At present, there are more than 700 medical device manufacturers in Shenzhen, with a total output value of more than 40 billion yuan, accounting for about 8% of the total market size of medical devices in our country, with one such as Mindray, Libang, Xianjian, open, steady and new industries Outstanding enterprises, of which more than 40 companies to enter 'billion club.'
The international market was the main direction of Shenzhen medical device products.Cai Qiao Wu introduced in 2016 top 10 diagnostic equipment exports in Shenzhen, a total of four companies list.Meriray medical device export and medical equipment exports first in the country, the other three Is to open, Libang and Kingway. Steady medical care for many years has been to maintain the national medical dressing the first or second position.
In recent years, due to the increase of domestic medical and health expenditures, the demand growth, and the government's policy support to the medical device industry, the proportion of Shenzhen medical device manufacturers in the domestic market has gradually risen. In 2016, nearly 60% of medical device companies in Shenzhen focused Domestic market.
Although in the field of segmentation, many enterprises in Shenzhen still occupy an advantage, but it is worrying that the medical equipment industry in Shenzhen once thriving status no longer, Suzhou, Shandong and other emerging areas of rapid catching up of medical equipment, the industry has been in Shenzhen Statistics show that from 2010 to 2015, the annual output value of the Shenzhen medical device industry increased from 16.303 billion yuan to 270.13 billion yuan, a compound annual growth rate of 11.37%; the proportion of output value dropped from 19.4% in 2005 to Compared with 8.8% in 2015. In contrast, from 2010 to 2015, the annual output value of medical equipment industry in Suzhou increased from 9.87 billion yuan to 22.0 billion yuan, maintaining a growth rate of about 20%. The gap with Shenzhen has been narrowing.
The problem - the lack of medical device industry core innovation park
Shenzhen, why the advantages of medical equipment industry will be reduced?
Last year, Shenzhen Municipal Committee of Jiu San Society conducted a survey on the medical device industry in Shenzhen and found that the relocation of Shenzhen medical device enterprises increased significantly. In 2008, an innovative team headed by Xue Min and an advanced hospital set up an innovative platform for high-end magnetic resonance imaging in Shenzhen In March, Lian Ying Medical was located in different places in Shanghai, and the sales of the company reached about 2 billion Yuan in 2015. The production of Huada Gene Sequencer was settled in Guanggu and Mindray set up a production base in Nanjing, and the steady medical production base was basically relocated to Hubei. In 2016, Shenzhen Anke also signed a contract with Dongguan Songshan Lake, planning to invest 440 million yuan to build Anke High-end Imaging Equipment Industrial Park.In addition, a number of innovative enterprises such as Hua Yin, Pumen and Feipeng have settled in Zhongshan of the Pearl River Delta, Dongguan Songshan Lake and other places, and gradually formed a peripheral medical equipment industry Shenzhen territory.
'With Shenzhen moving towards an international metropolis, the cost of the city has been on the rise. Some enterprises in the industrial cluster gradually moved to the periphery and now the Songshan Lake has formed a cluster of medical device subdivisions.' The layout and relocation of enterprises across regions, Shenzhen, but there is no core medical device industry innovation park to promote the new agglomeration of the industry is still a problem, the constraints of the industrial cluster effect. 'Once Nanshan District, Shenzhen medical equipment industry is a gathering place, the city's medical 80% of the output value of the equipment industry in Nanshan District, with the outflow of enterprises, Nanshan District, the output value of medical equipment accounted for only five percent of the city 'Cai Qiao Wu said Nanshan District, Shenzhen medical equipment industry is a microcosm.
On the other hand, Shenzhen medical device industry innovation output advantage is no longer.Shenzhen was once a synonym for medical device indigenous products, but in recent years, in addition to the gene sequencing sequencer, the new industrial biochemical chemiluminescence products in the country more Influence, there are few other innovative technologies and products that have great influence.From the beginning of 2014 CFDA promulgated the "Special Medical Device Approval Process", as of November 2016, China's approved innovative medical device product statistics, Shenzhen Has lagged behind in Shanghai, Beijing.
Compared with foreign medical equipment giants, Shenzhen medical equipment industry innovation investment is not enough.According to statistics, Shenzhen medical equipment industry in 2011 - 2016 R & D sales although maintained at between 8% -9.7% higher level, but the whole city The total investment in research and development of the industry is only about 15.6 billion yuan, less than the first-year research and development investment of Medtronic, the No. 1 medical equipment company in the world, and the research and development investment in 2016 was 2.223 billion U.S. dollars.
In terms of innovation foundation, there are only a few high-level medical colleges and high-level medical institutions in Shenzhen and a few major infrastructure facilities. "These led to insufficient research and clinical collaborative innovation in the medical device industry in Shenzhen, and therefore the launch of innovative products was relatively small," said Cai Qiangwu.
Advice - 'Releasing Targeted Supporting Policies and Services'
Since last year, thanks to the support of national policies, the development of China's medical device industry will enter the spring.With the double attack of the international giants and emerging regions, can Shenzhen's medical device industry return to the top spot?
Cai Qiao Wu said that the medical equipment industry in Shenzhen is based on the electronics industry. The mechatronic industry is well-developed and has a high degree of agglomeration. High-end medical equipment such as monitors, nuclear magnetic resonance and imaging diagnostics have developed rapidly with high added value. Coupled with China's introduction of policies focused on the development of imaging equipment, medical robots and other high-performance treatment equipment, and promote the localization of high-end medical equipment, which will help the development of medical equipment enterprises in Shenzhen.
In his view, the key is to introduce targeted industrial support policies. 'Outflow of Shenzhen medical enterprises is because the government support is not enough, the cost of production and high cost of living.' Cai said that although Shenzhen has introduced to support emerging industries However, these policies are inclusive. Compared with other high-tech industries such as IT, many medical device enterprises can not enjoy these policies and need to put in place policies and measures that specifically target the medical device industry.
'The development of the medical device industry is a long-term process. Only through rolling support can we truly mobilize the enthusiasm of the enterprise's research and development so that the entire industry will grow.' In addition, he also suggested that medical and pharmaceutical products with independent intellectual property rights Instruments quickly enter the market, the establishment of a public service platform for the development of the industry to provide a full range of services.
Measures - to move China International Medical Equipment Expo back to Shenzhen
Recently, the reporter also learned from Shenzhen Municipal Development and Reform Commission that Shenzhen will promote the transformation and upgrading of Shenzhen's medical device industry from several aspects, such as the construction of medical institutions, the collaborative innovation of production, study and research institutes, and improvement of industrial facilities.
For example, in the layout of clinical medicine conversion center, will speed up the construction of Shenzhen Academy of Medical Sciences, relying on Shenzhen Second People hospital , Shenzhen University of Medical Sciences of Peking University, University of Hong Kong, Huada Gene, etc. The Shenzhen Conversion Medicine Research Platform, the Shenzhen Precision Medicine Research Platform and the Shenzhen Biomedical Innovation Platform are all included in the five-year plan of urban infrastructure construction. Among them, the city Institute of Medical Sciences is the demonstration project construction and operation mode.
Medical equipment research and development and the transformation of results, can not be separated from the testing of authoritative testing institutions. Shenzhen Medical Device Testing and Biology medicine The project of safety evaluation center is listed as one of the major projects promoted by the municipal government and the public service platform of the top ten producer services in Shenzhen City. The total investment of the project is 860 million yuan, building a number of centers such as drug substitution, toxicology and animal testing, It is estimated that the construction of the main project will be completed in 2019. Upon the completion of the project, it will become the largest investment by the local governments in the state food and drug monitoring system and the most advanced facilities and equipment medical instruments Testing and pre-clinical safety evaluation research laboratory to meet the new medical products in Shenzhen preclinical evaluation studies and animal experiments.
The next step, Shenzhen will also actively seek medical equipment in the field of national branches settled in Shenzhen, apply for the establishment of the country in the deep drug Medical Device Technology Review Shenzhen Branch, and strive for the China International Medical Equipment Expo relocated to Shenzhen for Shenzhen enterprise In addition, Shenzhen will further innovate ways to support strategic emerging industries and future industry-specific funds, intensify its support and explore ways such as interest-free loans, financial leasing and post-industrial subsidies to encourage enterprises to develop new products and speed up clinical Test, expand the market at home and abroad. Written: Nanfang Daily reporter to RAIL
